LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi, an operating company of Fresenius, announced today that the Centers for Medicare and Medicaid Services (CMS) issued a permanent, product-specific ...
The SC formulation is now available in a prefilled syringe and an autoinjector. Tyenne ® (tocilizumab-aazg), a biosimilar to Actemra ® (tocilizumab), is now available in a subcutaneous (SC) ...
The MarketWatch News Department was not involved in the creation of this content. -- Tyenne(R) is the first tocilizumab biosimilar available with both an intravenous and subcutaneous formulation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback